Published in Arch Neurol on August 09, 2010
Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172 | NCT01222351
Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology (2013) 1.51
Body fluid biomarkers in Alzheimer's disease. Ann Transl Med (2015) 1.44
Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI. Acta Neuropathol (2011) 1.40
Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Arch Neurol (2011) 1.15
Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker. Alzheimers Res Ther (2013) 1.06
A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study. Mol Psychiatry (2013) 1.03
Verbal serial list learning in mild cognitive impairment: a profile analysis of interference, forgetting, and errors. J Int Neuropsychol Soc (2011) 1.02
MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice. J Neurosci (2013) 0.98
Nutrient intake and plasma β-amyloid. Neurology (2012) 0.93
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans. Alzheimers Dement (2015) 0.90
Cognition in non-demented diabetic older adults. Curr Aging Sci (2012) 0.85
Prenatal lead levels, plasma amyloid β levels, and gene expression in young adulthood. Environ Health Perspect (2012) 0.85
Long-term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of Alzheimer's disease. PLoS One (2015) 0.85
Plasma amyloid-β levels and prognosis in incident dementia cases of the 3-City Study. J Alzheimers Dis (2013) 0.84
The diagnostic value of controlled oral word association test-FAS and category fluency in single-domain amnestic mild cognitive impairment. Dement Geriatr Cogn Disord (2011) 0.81
Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels. PLoS One (2011) 0.80
Chronic dietary supplementation of 4% figs on the modification of oxidative stress in Alzheimer's disease transgenic mouse model. Biomed Res Int (2014) 0.78
Diet rich in date palm fruits improves memory, learning and reduces beta amyloid in transgenic mouse model of Alzheimer's disease. J Ayurveda Integr Med (2015) 0.78
Underrepresentation of African-Americans in Alzheimer's Trials: A Call for Affirmative Action. Front Aging Neurosci (2016) 0.77
A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer's disease. SAGE Open Med (2015) 0.77
Regional Hippocampal Atrophy and Higher Levels of Plasma Amyloid-Beta Are Associated With Subjective Memory Complaints in Nondemented Elderly Subjects. J Gerontol A Biol Sci Med Sci (2016) 0.75
Biomarkers of Alzheimer's disease risk in peripheral tissues; focus on buccal cells. Curr Alzheimer Res (2014) 0.75
Longitudinal Cognitive Profiles in Diabetes: Results From the National Alzheimer's Coordinating Center's Uniform Data. J Am Geriatr Soc (2017) 0.75
Abnormal amyloid β42 expression and increased oxidative stress in plasma of CKD patients with cognitive dysfunction: A small scale case control study comparison with Alzheimer's disease. BBA Clin (2017) 0.75
Association of Plasma β-Amyloid with Cognitive Performance and Decline in Chronic Kidney Disease. Mol Neurobiol (2016) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Alzheimer's disease: the amyloid cascade hypothesis. Science (1992) 13.80
Influence of education and occupation on the incidence of Alzheimer's disease. JAMA (1994) 8.43
The molecular pathology of Alzheimer's disease. Neuron (1991) 8.21
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain (2009) 7.20
Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci (2001) 6.32
Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain (2008) 6.29
Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study. Lancet Neurol (2006) 4.77
Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol (1992) 4.63
Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch Neurol (2007) 3.25
Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. Arch Neurol (2000) 2.66
Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk. Neurology (2003) 2.44
Education and rates of cognitive decline in incident Alzheimer's disease. J Neurol Neurosurg Psychiatry (2006) 2.29
Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease. Ann Neurol (1999) 1.96
Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol (1995) 1.85
Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc Natl Acad Sci U S A (2008) 1.84
Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study. Neurology (2009) 1.70
Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb (1991) 1.58
Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study. Arch Neurol (2008) 1.46
Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine. Neurobiol Aging (2006) 1.33
Selective reductions in plasma Abeta 1-42 in healthy elderly subjects during longitudinal follow-up: a preliminary report. Am J Geriatr Psychiatry (2005) 1.29
Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment. Neurology (2004) 1.23
Plasma levels of alpha beta peptides are altered in amnestic mild cognitive impairment but not in sporadic Alzheimer's disease. Acta Neurobiol Exp (Wars) (2005) 0.96
Isn't amyloid more than just a marker for Alzheimer disease? Neurology (2009) 0.79
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet (2008) 5.66
Mediterranean diet and risk for Alzheimer's disease. Ann Neurol (2006) 4.38
HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol (2002) 4.20
Physical activity, diet, and risk of Alzheimer disease. JAMA (2009) 4.11
Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA (2009) 4.01
Food combination and Alzheimer disease risk: a protective diet. Arch Neurol (2010) 3.99
Reading level attenuates differences in neuropsychological test performance between African American and White elders. J Int Neuropsychol Soc (2002) 3.83
A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol (2010) 3.52
Stroke and the risk of Alzheimer disease. Arch Neurol (2003) 3.49
Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry (2006) 3.44
Mediterranean diet and mild cognitive impairment. Arch Neurol (2009) 3.40
Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol (2008) 3.39
Imaging hippocampal function across the human life span: is memory decline normal or not? Ann Neurol (2002) 3.34
Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol (2005) 3.10
Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol (2006) 2.98
Relation of diabetes to mild cognitive impairment. Arch Neurol (2007) 2.86
Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol (2008) 2.69
Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis. Ann Neurol (2013) 2.68
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
Acculturation, reading level, and neuropsychological test performance among African American elders. Appl Neuropsychol (2004) 2.55
Mediterranean diet and Alzheimer disease mortality. Neurology (2007) 2.45
Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. Ann Neurol (2011) 2.44
Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol (2005) 2.39
Brain networks associated with cognitive reserve in healthy young and old adults. Cereb Cortex (2005) 2.37
Cognitive decline and literacy among ethnically diverse elders. J Geriatr Psychiatry Neurol (2005) 2.33
Literacy and memory decline among ethnically diverse elders. J Clin Exp Neuropsychol (2003) 2.27
Cognitive reserve and lifestyle. J Clin Exp Neuropsychol (2003) 2.27
The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch Neurol (2007) 2.21
Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann Neurol (2006) 2.21
Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia (2006) 2.17
Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke (2002) 2.13
Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke (2002) 2.08
Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol (2003) 2.08
Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and Whites. Arch Neurol (2009) 2.05
Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Curr Neurol Neurosci Rep (2004) 2.03
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol (2007) 1.94
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry (2008) 1.93
Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurol (2006) 1.92
Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study. Arch Neurol (2008) 1.92
A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol (2002) 1.91
Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol (2010) 1.91
Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr (2011) 1.91
Measures of adiposity and dementia risk in elderly persons. Arch Neurol (2007) 1.88
Age-related changes in brain activation during a delayed item recognition task. Neurobiol Aging (2006) 1.87
Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol (2009) 1.86
White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke (2008) 1.84
An event-related fMRI study of the neurobehavioral impact of sleep deprivation on performance of a delayed-match-to-sample task. Brain Res Cogn Brain Res (2004) 1.80
Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol (2010) 1.80
Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol (2004) 1.79
Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.78
A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis. Neural Comput (2005) 1.78
Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease. Neuroimage (2008) 1.74
Cognition assessment using the NIH Toolbox. Neurology (2013) 1.73
An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol (2006) 1.73
Increased sympathetic and decreased parasympathetic cardiovascular modulation in normal humans with acute sleep deprivation. J Appl Physiol (1985) (2005) 1.73
Education does not slow cognitive decline with aging: 12-year evidence from the victoria longitudinal study. J Int Neuropsychol Soc (2011) 1.66
Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects. Neuroimage (2003) 1.62
I. NIH Toolbox Cognition Battery (CB): introduction and pediatric data. Monogr Soc Res Child Dev (2013) 1.61
Lifecourse social conditions and racial and ethnic patterns of cognitive aging. Neuropsychol Rev (2008) 1.59
Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol (2010) 1.56
Association of shorter leukocyte telomere repeat length with dementia and mortality. Arch Neurol (2012) 1.55
Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve. Trends Cogn Sci (2013) 1.54
White matter hyperintensities and cognition: testing the reserve hypothesis. Neurobiol Aging (2009) 1.52
Memory and executive function impairment predict dementia in Parkinson's disease. Mov Disord (2002) 1.52
Late-life depression, mild cognitive impairment, and dementia. JAMA Neurol (2013) 1.52
Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease. J Cereb Blood Flow Metab (2007) 1.50
Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance. Neuroimage (2004) 1.49
Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch Neurol (2005) 1.48
Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol (2008) 1.48
Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Res (2009) 1.48
Positive evidence against human hippocampal involvement in working memory maintenance of familiar stimuli. Cereb Cortex (2004) 1.45
Essential tremor is associated with dementia: prospective population-based study in New York. Neurology (2009) 1.45
Altered DNA methylation in leukocytes with trisomy 21. PLoS Genet (2010) 1.44